Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer - Concepedia

Concepedia

Publication | Closed Access

Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer

151

Citations

15

References

2011

Year

Fabrice Pierre, Peter Chua, Sean O’Brien, Adam Siddiqui-Jain, Pauline Bourbon, Mustapha Haddach, Jerome Michaux, Johnny Nagasawa, Michael K. Schwaebe, Eric Stefan,

Molecular and Cellular Biochemistry

MedicineCancer GrowthImmune Checkpoint InhibitorAnti-cancer AgentPre-clinical CharacterizationPharmacologyCell BiologyCancer ResearchNovel TherapySmall MoleculesDrug Discovery

References

	Year	Citations

Page 1

Page 1